Just going through the literature on the website about the remestemcel-L trials on GVHD. Did they ever perform a double blinded study? All I can find is the single arm.
Thanks in advance. I'm currently working on a haematology team that specialises in BMT (not my speciality, just spending 10 weeks with them), and I'm gonna try and speak to some of the specialists about their thoughts.
I've got a couple patients with GVHD and I'd be interested in what they think.
Mesoblast Company Update - Webcast and Forward Thoughts, page-193
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |